Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT05018806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Proof-of-concept Study Evaluating Efficacy and Safety of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Who Are Inadequate Responders or Intolerant to Topical Corticosteroids
Study identification
- NCT ID
- NCT05018806
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Rilzabrutinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 8, 2021
- Primary completion
- Jun 22, 2023
- Completion
- Jun 22, 2023
- Last update posted
- Jul 12, 2026
2021 – 2023
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Antelope Valley Clinical Trials Site Number : 8400001 | Northridge | California | 91325 | — |
| Asthma and Allergy Associates, PC Site Number : 8400008 | Colorado Springs | Colorado | 80907 | — |
| Florida International Research Center Site Number : 8400002 | Miami | Florida | 33173 | — |
| Skin Sciences, PLLC Site Number : 8400005 | Louisville | Kentucky | 40217 | — |
| DS Research of Kentucky, LLC Site Number : 8400004 | Louisville | Kentucky | 40241 | — |
| Integrative Skin Care of MS/SKYCRNG Site Number : 8400011 | Ridgeland | Mississippi | 39157 | — |
| National Allergy and Asthma Research, LLC. Site Number : 8400007 | North Charleston | South Carolina | 29420 | — |
| Orion Clinical Research Site Number : 8400003 | Austin | Texas | 78759 | — |
| E.P.I.M.R.D dba Western Sky Research, Inc. Site Number : 8400009 | El Paso | Texas | 79903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05018806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05018806 live on ClinicalTrials.gov.